A recent analysis of an already CE-marked, AI-based system that identifies pneumothorax on chest radiographs revealed a weak point in what has largely been considered a reliable support tool.
The software is the first of its kind to achieve the FDA's approval for detecting, measuring and grading ARIA on MRI scans—a task that is critical in managing the disease.
Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
